News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Shukla Sanjay
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2023 |
4
| Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 336,096 options to buy
@ $2.195, valued at
$737.7k
|
|
| 02/06/2023 |
4
| Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Exercised 10,375 restricted stock units
@ $0 |
|
| 11/21/2022 |
4
| Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Bought 10,000 shares
@ $2.1405, valued at
$21.4k
|
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2022 |
4
| Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Bought 5,000 shares
@ $6.7613, valued at
$33.8k
|
|
| 11/15/2021 |
4
| Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Bought 2,500 shares
@ $8.575, valued at
$21.4k
|
|
| 05/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2020 |
4
| Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Bought 6,000 shares
@ $4.27, valued at
$25.6k
|
|
| 05/28/2020 |
4
| Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 80,000 options to buy
@ $4.06, valued at
$324.8k
|
|
| 02/07/2020 |
4
| Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Sold 745 shares
@ $4.03, valued at
$3k
Granted 39,327 options to buy
@ $4.39, valued at
$172.6k
Exercised 1,786 restricted stock units
@ $0 |
|
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2018 |
4
| Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 300,000 options to buy
@ $3.3, valued at
$990k
|
|
| 11/03/2017 |
4
| Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 450,000 options to buy
@ $4, valued at
$1.8M
|
|
| 02/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/15/2016 |
4
| Shukla Sanjay (Chief Medical Officer) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 27,500 options to buy
@ $3.06, valued at
$84.2k
|
|
| 04/01/2016 |
4
| Shukla Sanjay (Chief Medical Officer) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 163,000 options to buy
@ $4.86, valued at
$792.2k
|
|
|
|